Actinium Pharmaceuticals Secures $3,325,860 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7cace8f4-dd54-4546-946a-e2ca7acdbe39
Date
1/8/2014
Company Name
Actinium Pharmaceuticals
Mailing Address
501 Fifth Avenue 4th Floor New York, NY 10017
Company Description
Actinium Pharmaceuticals, Inc. (API) is a privately held biopharmaceutical company specialized in the development of cancer drugs.
Website
http://www.actiniumpharmaceuticals.com
Transaction Type
Venture Equity
Transaction Amount
$3,325,860
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
M&A Terms
Venture Investor
Undisclosed